UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | I | J | K | M | N | O | P | S | T | U | V | W
Number of items: 70.

A

Ataman, OU; Bentzen, SM; Saunders, MI; Dische, S; (2001) Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced nonsmall-cell lung cancer: A competing risks analysis. British Journal of Cancer , 85 (8) 1113 - 1118.

B

BBC, 6ON; (2001) Thalidomide trial in lung cancer. UNSPECIFIED

BBC, N; (2001) 'My hope for Thalidomide cure'. UNSPECIFIED

BBC, NATIBFW; BBC, OTN; BBC, N2B; (2001) Thalidomide is cancer weapon. UNSPECIFIED

BBC, R4IBRH; (2001) UNSPECIFIED UNSPECIFIED

Bownes, PJ; Hoskin, PJ; Ostler, P; (2001) Quality assurance for fractionated highdose rate afterloading brachytherapy of prostate cancer. In: Clinical Oncology. (pp. S7 - ?).

Bownes, PJ; Ostler, P; Hoskin, PJ; (2001) The effect of catheter movement on implant quality for fractionated high dose rate afterloading brachytherapy of prostate cancer. In: Radiotherapy And Oncology. (pp. S30 - ?).

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emett, J; Wong, WL; (2001) Evaluation of clinical complete response to neoadjuvant chemotherapy in primary breast cancer using (F-18)- fluorodeoxyglucose positron emission tomography. British Journal of Cancer , 85 50 - 50.

Burcombe, RJ; Makris, A; Richman, PI; Pittam, M; Daley, F; Nobe, S; Wilson, GD; (2001) Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer. British Journal of Cancer , 85 50 - 50.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, P; Meyer, T; ... Hilson, AJW; + view all (2001) Use of radiolanreotice to treat somatostatin receptor positive tumours. European Journal of Nuclear Medicine , 28 (8) S480 - ?.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, PL; Meyer, T; ... Hilson, AJW; + view all (2001) Treating somatostatin receptor positive tumours with radiolanreotide. European Journal of Nuclear Medicine , 28 (8) OS253 - ?.

C

Craddock, C; Spanswick, V; Mahendra, P; Sekhar, M; Hartley, JA; (2001) Repair of DNA interstarand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. In: British Journal of Haematology. (pp. 41 - ?).

D

Daily, S; (2001) Hell drug for cancer.

David, D; (2001) Thalidomide in trials to treat lung cancer. Daily Telegraph 4 - ?.

David, F; (2001) Birth defects drug may return. Financial Times

Dickson, J; Bownes, P; Ostler, P; Hoskin, PJ; (2001) Combined external beam and brachytherapy boost for localised prostate cancer: A report of procedural complications and acute radiation toxicity. In: British Journal of Cancer. (pp. 89 - 89).

F

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, RAB; R, HJ; (2001) A mouse model for calculating the absorbed beta dose, from 131I and 90Y labelled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumour. Radiation Research , 156 28 - 35.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; ... Begent, RHJ; + view all (2001) Effectiveness of radiolabelled antibodies for radio- immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. International Journal of Radiation Biology , 77 (4) 507 - 517.

G

Gary, J; (2001) Thalidomide brilliant at beating Lung Cancer. The Mirror 24 - ?.

Goodchild, K; Hill, SA; Sibtain, A; Chaplin, DJ; Makris, A; (2001) Assessment of microregional blood flow in human breast carcinomas after administration of anthracycline chemotherapy. British Journal of Cancer , 85 48 - 48.

H

Hartley, JA; (2001) Alkylating agents. In: Souhami, RL and Tannock, IF and Hohenberger, P and Horiot, JC, (eds.) Oxford Textbook of Oncology. (639 - 654).

Hoskin, PJ; Chow, EL; Wu, J; Coia, L; (2001) Uncertainties in the measurement of metastatic bone pain. In: Clinical Oncology. (pp. S5 - ?).

Hoskin, PJ; Dickson, J; (2001) Clincal uncertainties in the use of radical nodal irradiation in Hodgkins disease. In: Clinical Oncology. (pp. S3 - ?).

Hoskin, PJ; Dickson, J; (2001) Survival and morbidity after post operative vaginal va. In: British Journal of Cancer. (pp. 90 - ?).

Hoskin, PJ; Yarnold, JR; Roos, DR; Bentzen, S; (2001) Radiotherapy for bone metastases. Clinical Oncology , 13 (2) 88 - 90.

I

ITN, NLSIBRB; (2001) Thalidomide: new use for drug. UNSPECIFIED

J

Jacqui Thornton, MR; (2001) Can the drug which did this cure cancer? Thalidomide shrinks tumours. The Sun 39 - ?.

James, M; (2001) Thalidomide may fight cancer. Independent

James, M; (2001) Thalidomide may fight cancer. Tablets that caused horrific birth defects thought to help shrink tumours. The Guardian 2 - ?.

Jenny, H; (2001) Thalidomide therapy. Disgraced drug offers hope in lung cancer fight. Daily Mail 39 - ?.

Jeremy, L; (2001) Thalidomide is used to treat lung cancer. The Independent

Jo, H; (2001) Thalidomide hope for Cancer. GP Magazine 33 - ?.

John, C; (2001) Thalidomide for cancer victims. Daily Express

K

Kiakos, K; Brooks, N; Hartley, JA; Toth, J; Lee, M; (2001) Design, synthesis,cytotoxicity and sequence specificity of N-methylpyrrole C-and N-terminus linked seco-cyclopropylindole hybrid molecules. In: Proceeding of American Association for Cancer Research. (pp. 1374 - ?).

Kiakos, K; Brooks, N; McHugh, PJ; Loward, T; Lee, M; Hartley, JA; (2001) Repair of seqence specific adenine-N3 alkylations in the minor groove of DNA. In: Proceeding of American Association for Cancer Research. (pp. 3737 - ?).

M

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; ... Linch, D; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 15 (97) 2991 - 2997.

Makris, A; Burcombe, RJ; Cladd, H; Smith, JM; Makris, M; (2001) Raised plasma homocysteine levels in women with metastatic breast cancer. British Journal of Cancer , 85 26 - 26.

Meyer, T; Davidson, B; Hochhauser, D; Dhillon, P; Begent, R; (2001) Fibrolamellar Carcinoma: a Strategy for Management. In: Journal of Clinical Oncology. (pp. 2311 - ?).

N

Nathan, PD; Walker, D; Bridle, H; Ross, A; Stevenson, A; Lee, SM; ... Gore, M; + view all (2001) A phase II study investigating the use of thalidomide in conjunction with interferon-alpha in patients with metastatic renal cell carcinoma. In: (Proceedings) 2001 ASCO Annual Meeting/37th Annual Meeting, San Francisco, California.. (pp. 265a - ?). Proceedings of the American Society of Clinical Oncology

Nigel, H; (2001) Thalidomide returns in lung cancer battle. The Times 12 - ?.

Nutting, C; Short, S; (2001) Where now with training in clinical oncology? Clinical Oncology , 13 4 - 5.

O

Osborne, M; Makris, A; Hoskin, PJ; Lowe, J; Emmott, J; Wong, WL; (2001) The role of FDG whole body positron emission tomography in metastatic carcinoma of unknown primary site. British Journal of Cancer , 85 90 - 90.

Osborne, M; Shah, N; Hoskin, PJ; Powell, MG; Anthony-Pillau, R; Glynne-Jones, R; Makris, A; (2001) Low dose folinic acid with infusional and bolus 5fluorouracil in advanced colorectal carcinoma. British Journal of Cancer , 85 44 - 44.

Osborne, ME; Brown, RSD; Hoskin, PJ; (2001) Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid. Clinical Oncology , 13 (5) 370 - 371.

P

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, G; Boden, R; ... Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, regios-specific therapies. In: Proceeding of American Association for Cancer Research. (pp. 871 - ?).

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, GM; Boden, R; ... and Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, region-specific therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 871 - ?).

S

Shah, N; Joiner, MC; Saunders, MI; (2001) An evaluation of human skin epidermal cells for hyper- radiosensitivity. British Journal of Cancer , 85 16 - 16.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. In: British Journal of Cancer. (pp. 98 - 98).

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KAAB; R, HJ; (2001) Immunogenicity of carboxypeptidase G2(CPG2) enzyme in ADEPT. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 98 - ?).

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; ... Begent, RHJ; + view all (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. British Journal of Cancer , 85 99 - 99.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KA; Begent, RHJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: Proceeding of American Association for Cancer Research. (pp. 136 - ?).

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KAAB; R, HJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 136 - ?).

Short, S; (2001) Thalidomide as an anti-angiogenic agent in recurrent gliomas. Journal of Neuro-Oncology , 51 41 - 55.

Short, SC; Kelly, J; mayes, CR; Woodcock, M; Joiner, MC; (2001) Low-dose hypersensitivity after fractionated low-dose irradiation. International journal of radiation biology , 77 (6) 655 - 664.

Short, SC; Traish, D; Dowe, A; Hines, F; Gore, M; Brada, M; (2001) Thalidomide as an anti-angiogenic agent in relapsed gliomas. Journal of Neuro-Oncology , 51 (1) 41 - 45.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2001) Tumour hypoxia and vascularity in lymphoma. British Journal of Cancer , 85 36 - 36.

Sky, NRTM; (2001) Thalidomide could be used to treat lung cancer. UNSPECIFIED

Spanswick, V; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hochhauser, D; Hartley, J; (2001) Repair of melphalan induced DNA interstrand crosslinks in patients who relapse after autologous stem cell transplantation for multiple myeloma. In: (pp. 3174 - ?).

T

Timothy, AR; Girling, DJ; Saunders, MI; Macbeth, F; Hoskin, PJ; (2001) Radiotherapy for inoperable lung cancer. Clinical Oncology , 13 (2) 86 - 87.

Todd, R; Boddy, AV; Verrill, M; Sludden, J; Griffin, MJ; Elliott, S; ... Calvert, AH; + view all (2001) Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate. Clinical Cancer Research , 7 (11) 115 - ?.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. Clinical Cancer Research , 7 (11) 703 - ?.

U

UCL, N; (2001) Thalidomide to be used in cancer fight. 14 - ?.

UCL, NFP; (2001) 'Thalidomide tested against cancer'.

V

Venables, K; Winfield, E; Ariad, EGA; Hoskin, PJ; (2001) Dosimetric uncertainties in the delivery of breast radiotherapy. Clinical Oncology , 13 (2) S2 - ?.

W

Wendy, V; (2001) Thalidomide could treat lung cancer. Metro 9 - ?.

Wilson, E; Makris, A; Novell, IR; (2001) Implementation of the two week rule has little effect on diagnostic yield in colorectal cancer. In: European Journal of Cancer. (pp. S121 - ?).

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) Film dosimetry, at depth, of the matchplane between breast tangential fields and anterior supraclavicular fossa field. In: Radiotherapy And Oncology. (pp. S206 - ?).

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) In vivo disimertry for patients in the START Trial. In: Radiotherapy And Oncology. (pp. S209 - ?).

Woll, PJ; Thatcher, N; Lomax, L; Hodgetts, J; Lee, SM; Burt, PA; ... Pettengell, R; + view all (2001) Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomised phase II trial in small cell lung cancer. Journal of Clinical Oncology , 19 (3) 712 - 719.

This list was generated on Mon Feb 23 18:33:33 2015 GMT.